BMO cuts Dynatrace target price to $60 from $70
DT•BMO cut its target price for Dynatrace to $60 from $70.
Related News
Lifecore Biomedical Q3 revenue misses estimates as CDMO, HA sales decline
LFCR•
Ball Corp: Truist Securities cuts target price to $76 from $78
BALL•
Geron swings to Q3 2026 net profit of $1.35 million from year-earlier loss
GERN•
AC Immune Q3 net loss narrows as revenue rises
ACIU•
Seres Therapeutics Q3 net loss widens on impairment charge
MCRB•